These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 20659323)

  • 1. MYB suppresses differentiation and apoptosis of human breast cancer cells.
    Drabsch Y; Robert RG; Gonda TJ
    Breast Cancer Res; 2010; 12(4):R55. PubMed ID: 20659323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CDK9 inhibitors selectively target estrogen receptor-positive breast cancer cells through combined inhibition of MYB and MCL-1 expression.
    Mitra P; Yang RM; Sutton J; Ramsay RG; Gonda TJ
    Oncotarget; 2016 Feb; 7(8):9069-83. PubMed ID: 26812885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intrinsic mechanism of estradiol-induced apoptosis in breast cancer cells resistant to estrogen deprivation.
    Lewis JS; Meeke K; Osipo C; Ross EA; Kidawi N; Li T; Bell E; Chandel NS; Jordan VC
    J Natl Cancer Inst; 2005 Dec; 97(23):1746-59. PubMed ID: 16333030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and regulation of c-Myb target genes in MCF-7 cells.
    Quintana AM; Liu F; O'Rourke JP; Ness SA
    BMC Cancer; 2011 Jan; 11():30. PubMed ID: 21261996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Buthionine sulfoximine sensitizes antihormone-resistant human breast cancer cells to estrogen-induced apoptosis.
    Lewis-Wambi JS; Kim HR; Wambi C; Patel R; Pyle JR; Klein-Szanto AJ; Jordan VC
    Breast Cancer Res; 2008; 10(6):R104. PubMed ID: 19061505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells.
    Cesi V; Casciati A; Sesti F; Tanno B; Calabretta B; Raschellà G
    Cell Cycle; 2011 Dec; 10(23):4149-61. PubMed ID: 22101269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anterior gradient-2 plays a critical role in breast cancer cell growth and survival by modulating cyclin D1, estrogen receptor-alpha and survivin.
    Vanderlaag KE; Hudak S; Bald L; Fayadat-Dilman L; Sathe M; Grein J; Janatpour MJ
    Breast Cancer Res; 2010; 12(3):R32. PubMed ID: 20525379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The estrogen receptor influences microtubule-associated protein tau (MAPT) expression and the selective estrogen receptor inhibitor fulvestrant downregulates MAPT and increases the sensitivity to taxane in breast cancer cells.
    Ikeda H; Taira N; Hara F; Fujita T; Yamamoto H; Soh J; Toyooka S; Nogami T; Shien T; Doihara H; Miyoshi S
    Breast Cancer Res; 2010; 12(3):R43. PubMed ID: 20579400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Posttranscriptional regulation of the c-myb proto-oncogene in estrogen receptor-positive breast cancer cells.
    Gudas JM; Klein RC; Oka M; Cowan KH
    Clin Cancer Res; 1995 Feb; 1(2):235-43. PubMed ID: 9815978
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen prevents sustained COLO-205 human colon cancer cell growth by inducing apoptosis, decreasing c-myb protein, and decreasing transcription of the anti-apoptotic protein bcl-2.
    Wilkins HR; Doucet K; Duke V; Morra A; Johnson N
    Tumour Biol; 2010 Jan; 31(1):16-22. PubMed ID: 20237898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pure antiestrogen ICI 182780 is more effective in the induction of apoptosis and down regulation of BCL-2 than tamoxifen in MCF-7 cells.
    Diel P; Smolnikar K; Michna H
    Breast Cancer Res Treat; 1999 Nov; 58(2):87-97. PubMed ID: 10674872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trefoil factor 3 is oncogenic and mediates anti-estrogen resistance in human mammary carcinoma.
    Kannan N; Kang J; Kong X; Tang J; Perry JK; Mohankumar KM; Miller LD; Liu ET; Mertani HC; Zhu T; Grandison PM; Liu DX; Lobie PE
    Neoplasia; 2010 Dec; 12(12):1041-53. PubMed ID: 21170268
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism of and requirement for estrogen-regulated MYB expression in estrogen-receptor-positive breast cancer cells.
    Drabsch Y; Hugo H; Zhang R; Dowhan DH; Miao YR; Gewirtz AM; Barry SC; Ramsay RG; Gonda TJ
    Proc Natl Acad Sci U S A; 2007 Aug; 104(34):13762-7. PubMed ID: 17690249
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptional regulators Myb and BCL11A interplay with DNA methyltransferase 1 in developmental silencing of embryonic and fetal β-like globin genes.
    Roosjen M; McColl B; Kao B; Gearing LJ; Blewitt ME; Vadolas J
    FASEB J; 2014 Apr; 28(4):1610-20. PubMed ID: 24371119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Novel Effect of β-Adrenergic Receptor on Mammary Branching Morphogenesis and its Possible Implications in Breast Cancer.
    Gargiulo L; May M; Rivero EM; Copsel S; Lamb C; Lydon J; Davio C; Lanari C; Lüthy IA; Bruzzone A
    J Mammary Gland Biol Neoplasia; 2017 Mar; 22(1):43-57. PubMed ID: 28074314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-Myb Enhances Breast Cancer Invasion and Metastasis through the Wnt/β-Catenin/Axin2 Pathway.
    Li Y; Jin K; van Pelt GW; van Dam H; Yu X; Mesker WE; Ten Dijke P; Zhou F; Zhang L
    Cancer Res; 2016 Jun; 76(11):3364-75. PubMed ID: 27197202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of apoptosis in mammary gland by a pure anti-estrogen ICI 182780.
    Lim KB; Ng CY; Ong CK; Ong CS; Tran E; Nguyen TT; Chan GM; Huynh H
    Breast Cancer Res Treat; 2001 Jul; 68(2):127-38. PubMed ID: 11688516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined histone deacetylase inhibition and tamoxifen induces apoptosis in tamoxifen-resistant breast cancer models, by reversing Bcl-2 overexpression.
    Raha P; Thomas S; Thurn KT; Park J; Munster PN
    Breast Cancer Res; 2015 Feb; 17(1):26. PubMed ID: 25848915
    [TBL] [Abstract][Full Text] [Related]  

  • 19. c-Myb down-regulation is associated with human colon cell differentiation, apoptosis, and decreased Bcl-2 expression.
    Thompson MA; Rosenthal MA; Ellis SL; Friend AJ; Zorbas MI; Whitehead RH; Ramsay RG
    Cancer Res; 1998 Nov; 58(22):5168-75. PubMed ID: 9823328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bortezomib enhances the efficacy of fulvestrant by amplifying the aggregation of the estrogen receptor, which leads to a proapoptotic unfolded protein response.
    Ishii Y; Papa L; Bahadur U; Yue Z; Aguirre-Ghiso J; Shioda T; Waxman S; Germain D
    Clin Cancer Res; 2011 Apr; 17(8):2292-300. PubMed ID: 21292820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.